pocketful logo
Medico Remedies Ltd logo

Medico Remedies Ltd

NSE: MEDICO BSE: 540937

47.01

(-1.01%)

Sat, 14 Feb 2026, 02:03 am

Medico Remedies Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

  • Market Cap

    392.68

  • Net Profit

    10.09

  • P/B

    6.92

  • Sector P/E

    39.96

  • P/E

    42.70

  • EV/EBITDA

    25.21

  • Debt/Equity (Industry)

    0.22

  • Interest Cover (Industry)

    10.71

  • ROCE (Industry)

    11.89

  • RONW (Industry)

    11.62

  • ROE

    17.57

  • ROCE

    21.31

  • Debt/Equity

    0.20

  • EPS (TTM)

    1.37

  • Dividend Yield

    0

  • Book Value

    8.06

  • Interest Cover

    12.64

Analysis

all

thumbs up icon

Pros

  • Medico Remedies is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Medico Remedies is profitable, therefore cash runway is not a concern.
  • Medico Remedies is profitable, therefore cash runway is not a concern.
  • Debt is covered by short term assets, assets are 3.5x debt.
  • Medico Remedies's cash and other short term assets cover its long term commitments.
thumbs up icon

Cons

  • Unable to evaluate Medico Remedies's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Medico Remedies's dividend against the top 25% market benchmark as the company has not reported any payouts.
  • Operating cash flow is negative therefore debt is not well covered.
  • Medico Remedies's level of debt (52.1%) compared to net worth is high (greater than 40%).
  • High level of physical assets or inventory.

Read More

Financials

No Result Found

Read More

Ratios

No Result Found

Read More

Shareholding

ShareholdersDEC 2025SEPT 2025JUN 2025MAR 2025DEC 2024
Promoters61.3861.3862.5963.7966.83
FII0.490.300.070.120.39
DII00.010.010.010.78
Public38.1338.3037.3336.0832.00
Government00000

Read More

Technical Analysis

RSI

-

MACD

-

50 DMA

-

200 DMA

-

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic-------
Fibonacci-------
Camarilla-------

Pivots Level: Classic

R3

+-

-

R2

+-

-

R1

+-

-

-
-
Pivot Point
LTP: -

S1

--

-

S2

--

-

S3

--

-

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    -

  • 20-EMA

    -

  • 30-EMA

    -

  • 50-EMA

    -

  • 100-EMA

    -

  • 200-EMA

    -

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
12 Feb 2026board-meetingsQuarterly Results
13 Nov 2025board-meetingsQuarterly Results
05 Aug 2025agm
20 Aug 2024agm
21 Jul 2023agm
02 Feb 2023split1:5 Splits of Equity Shares16 Mar 2023
01 Sept 2022agm
10 Nov 2021bonus3:1 Bonus Issue of Equity Shares17 Nov 2021
08 Sept 2021agm
24 Aug 2020agm

Read More

Peer Comparison

No Result Found

Medico Remedies Ltd logo

Medico Remedies Ltd

Cipla Ltd logo

Cipla Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Read More

Medico Remedies Ltd About

Medico Remedies is principally engaged in pharmaceutical business. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1994

Headquarters

CEO

Haresh Mehta

Employees

Contact

Website icon

Website

http://www.medicoremedies.com

Email icon

Email

info@medicoremedies.com

Phone icon

Phone

91-22-2670 1055/66

Location icon

Location

1105/1106 11-Flr Hubtown Solar, N S Phadke Marg Andheri East, Mumbai, Maharashtra, 400069

Read More

Medico Remedies Ltd Company History

YearHistory
No Result Found

Read More

Deals

Client NameOrder SideQTYAvg PriceDate
ALTIZEN VENTURES LLPSell70695052.6923 Jan 2026
ALTIZEN VENTURES LLPBuy8654525423 Jan 2026
VISHAL MAHESH WAGHELABuy51000053.4123 Jan 2026
ARYAMAN CAPITAL MARKETS LIMITEDSell65000048.0224 Sept 2025
PASHUPATI CAPITA SER PVT LTDBuy15200048.9927 Jun 2025
PASHUPATI CAPITA SER PVT LTDSell120598541.527 Jun 2025
PASHUPATI CAPITA SER PVT LTDBuy17119950.8418 Jun 2025
PASHUPATI CAPITA SER PVT LTDSell55672850.4218 Jun 2025
VISHAL MAHESH WAGHELABuy70032949.1728 Mar 2025
VISHAL MAHESH WAGHELASell70032946.7928 Mar 2025

Read More

Medico Remedies Ltd News

Medico Remedies Q3 FY26 Results: Revenue Up 48.6%

Medico Remedies Limited reported strong Q3 FY26 performance with revenue rising 48.6% YoY to ₹5,868.29 lakhs and net profit growing 9.6% to ₹287.23 lakhs for quarter ended December 31, 2025.

12 Feb 2026

co actions results

Medico Remedies Secures ₹37.17 Cr UP Govt Order

Medico Remedies Limited secured a government supply order worth ₹37.17 crores from Uttar Pradesh Medical Supplies Corporation Limited for multiple drug supplies to be completed by October 2026.

27 Jan 2026

co actions results

Medico Remedies Secures ₹73 Crore Order

Medico Remedies has secured a significant order worth ₹73 crore, representing a substantial business development for the pharmaceutical company with a current market capitalisation of ₹390 crore.

20 Jan 2026

co actions results

Medico Remedies Reports Strong Q2 Performance with Revenue Growth and Improved Profitability

Medico Remedies Limited reported quarterly revenue of Rs 526.35 lakh and net profit of Rs 356.82 lakh for the quarter ended September 30, 2025, with half-year revenue reaching Rs 932.69 lakh and net profit of Rs 438.63 lakh. The pharmaceutical formulations manufacturer showed significant growth with international sales contributing Rs 467.54 lakh compared to domestic sales of Rs 54.29 lakh in the latest quarter.

14 Nov 2025

earnings

Medicore Remedies Receives GMP Compliance Certificate from Ukraine's State Service on Medicines and Drugs Control

Medicore Remedies' Palghar manufacturing facility received GMP compliance certification from Ukraine's State Service on Medicines and Drugs Control on 10 November, 2025, following a successful inspection. The PIC/S certification will enhance the facility's global credibility and facilitate access to regulated markets including Thailand, Singapore, Malaysia, Jordan, and Iraq.

14 Nov 2025

corporate action

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800